A structured education programme for specialist prescribers of cannabinoid medicines. 13 modules covering source governance, pharmacology, evidence assessment, patient selection, dosing, safety, clinical pathways, consent, and clinic governance.
Evidence matrix, patient education, interaction guide, clinic redirect. Product-agnostic and non-promotional.
Education modules, checklists, monitoring tools, consent templates. Can reference NWPT-SM32300 in prescriber-only modules.
Prescriber-only, source-controlled, non-promotional. IB-aligned scientific information with CSR validation requirements.
Complete all modules and achieve 80% on the final assessment to receive certification.
Each module includes downloadable tools for clinical practice. Access them within individual module pages.
This material is educational and non-promotional. It does not constitute medical advice, prescribing advice, or a recommendation to use any medicine. Any use of an unlicensed medicine requires patient-specific clinical justification, informed consent, monitoring, pharmacovigilance and compliance with applicable regulatory requirements.